Overview

omalizumab


Show Summary Details

Quick Reference

(oh-mal-i-zoo-mab)

a monoclonal antibody administered by subcutaneous injection in the treatment of severe allergic asthma that has not responded to standard therapy. Trade name: Xolaire.

Subjects: Clinical Pharmacology and Therapeutics.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.